Código QR (código de barras bidimensional)

Long-term comparative analysis of secukinumab versus TNFα inhibitors in patients with spondyloarthritis: treatment persistence is differentially affected by disease phenotype, obesity and sex

Abstract Background The anti-interleukin 17A agent secukinumab has been approved for the treatment of spondyloarthritis (SpA) patients as an alternative to tumor necrosis factor inhibitors (TNFis). Our aim was to compare long-term treatment persistence and relevant effect modifiers, as well as 6-mon...

Fuld beskrivelse

Na minha lista:
Principais autores: Irini D. Flouri, Argyro Repa, Nestor Avgoustidis, Sofia Pitsigavdaki, Eleni Kalogiannaki, Konstantina Kalligianni-Sofikiti, Evgenia Emmanouilidou, Eleni Marolachaki, George Bertsias, Prodromos Sidiropoulos
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2025-11-01
Serier:Arthritis Research & Therapy
Fag:
Spondyloarthritis
Secukinumab
TNF inhibitors
Axial spondyloarthritis
Psoriatic arthritis
Response
Online adgang:https://doi.org/10.1186/s13075-025-03664-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker